BRPI0605508A - métodos para estabilização de composições oftálmicas - Google Patents

métodos para estabilização de composições oftálmicas

Info

Publication number
BRPI0605508A
BRPI0605508A BRPI0605508-7A BRPI0605508A BRPI0605508A BR PI0605508 A BRPI0605508 A BR PI0605508A BR PI0605508 A BRPI0605508 A BR PI0605508A BR PI0605508 A BRPI0605508 A BR PI0605508A
Authority
BR
Brazil
Prior art keywords
stabilizing
methods
ophthalmic compositions
ophthalmic
stabilizing ophthalmic
Prior art date
Application number
BRPI0605508-7A
Other languages
English (en)
Inventor
Azaam Alli
Shivkumar Mahadevan
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of BRPI0605508A publication Critical patent/BRPI0605508A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"MéTODOS PARA ESTABILIZAçãO DE COMPOSIçõES OFTáLMICAS". A presente invenção refere-se a um método que compreende estabilizar, durante a colocação na autoclave, um composto oftálmico instável à oxidação dissolvido em uma solução oftálmica pela incorporação de uma quantidade efetiva de estabilização de pelo menos um polímero rico em elétrons na referida solução oftálmica.
BRPI0605508-7A 2005-09-30 2006-09-29 métodos para estabilização de composições oftálmicas BRPI0605508A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/240,930 US20070077302A1 (en) 2005-09-30 2005-09-30 Methods for stabilizing ophthalmic compositions

Publications (1)

Publication Number Publication Date
BRPI0605508A true BRPI0605508A (pt) 2007-09-04

Family

ID=37561295

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0605508-7A BRPI0605508A (pt) 2005-09-30 2006-09-29 métodos para estabilização de composições oftálmicas

Country Status (11)

Country Link
US (1) US20070077302A1 (pt)
EP (1) EP1774961A3 (pt)
JP (1) JP2007099769A (pt)
KR (1) KR20070037402A (pt)
CN (1) CN1939277A (pt)
AR (1) AR056558A1 (pt)
AU (1) AU2006225171B2 (pt)
BR (1) BRPI0605508A (pt)
CA (1) CA2561694A1 (pt)
SG (1) SG131102A1 (pt)
TW (2) TWI427052B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0710085B8 (pt) * 2006-03-31 2021-05-25 Vistakon Pharmaceutical Llc composições oftálmicas e seus kits
AU2013201367B2 (en) * 2006-03-31 2014-07-17 Johnson & Johnson Vision Care, Inc. Ocular allergy treatments
UA94938C2 (ru) * 2006-03-31 2011-06-25 ВИСТЕКОН ФАРМАСЬЮТИКАЛС, ЭлЭлСи Офтальмическая композиция для лечения клинических симптомов глазной аллергии, которая содержит алкафтадин или его производное (варианты)
US20100226999A1 (en) * 2009-03-06 2010-09-09 Tracy Quevillon-Coleman Process for forming stabilized ophthalmic solutions
TWI412381B (zh) * 2009-03-23 2013-10-21 Far Eastern New Century Corp Contact lens cleaning and maintenance liquid
CN109641059B (zh) * 2016-08-23 2022-08-30 大塚制药株式会社 具有改善的防腐效力或光稳定性的眼科药物组合物
WO2020005416A1 (en) * 2018-06-27 2020-01-02 Bausch & Lomb Incorporated Packaging solutions
CN112807275B (zh) * 2019-11-15 2022-05-20 湖北远大天天明制药有限公司 一种眼用组合物及其制备方法与应用
CN111450051B (zh) * 2020-04-21 2022-03-18 武汉贝参药业股份有限公司 一种富马酸酮替芬口服溶液的制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2422904A1 (de) * 1974-05-11 1975-11-20 Hoechst Ag Niedermolekulares poly-n-vinyl-nmethyl-acetamid fuer die anwendung in arzneimittelzubereitungen
US4911920A (en) * 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
US5554367A (en) * 1984-10-31 1996-09-10 Alcon Laboratories, Inc. Compositions for treatment of glaucoma
US5705485A (en) * 1987-09-18 1998-01-06 Ethicon, Inc. Gel formulations containing growth factors
IL101850A (en) * 1991-06-13 1996-01-31 Janssen Pharmaceutica Nv 11-(4-Piperidinyl)-imidazo (2,1-b) (3) benzazepine derivatives their preparation and pharmaceutical compositions containing them
DE4209722C3 (de) * 1992-03-25 1997-06-19 Medproject Pharma Entwicklungs Tropfbares Gel für die Augenheilkunde
JPH0725750A (ja) * 1993-05-20 1995-01-27 Medproject Pharma Entwickl & Vertriebs Gmbh 眼科用ゲル
US20020193828A1 (en) * 2001-06-14 2002-12-19 Cook Incorporated Endovascular filter
WO1998006438A2 (en) * 1996-08-12 1998-02-19 Medlogic Global Corporation Composition for pharmaceutical applications
JPH10139666A (ja) * 1996-11-15 1998-05-26 Sawai Seiyaku Kk 液剤およびその製造方法
EP0938896A1 (en) * 1998-01-15 1999-09-01 Novartis AG Autoclavable pharmaceutical compositions containing a chelating agent
JP2002510627A (ja) * 1998-04-02 2002-04-09 ノバルティス アクチエンゲゼルシャフト 抗酸化剤の特別な使用により医薬組成物を安定化するための方法
AU7936198A (en) * 1998-07-01 2000-01-24 Lead Chemical Co., Ltd. Ketotifen preparation for percutaneous absorption
US6444710B1 (en) * 1998-10-27 2002-09-03 Alcon Manufacturing, Ltd. Use of certain fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositions
US6777429B1 (en) * 1999-07-23 2004-08-17 Novartis Ag Ophthalmic composition
AR034372A1 (es) * 2001-06-08 2004-02-18 Novartis Ag Composiciones farmaceuticas
WO2002100436A2 (en) * 2001-06-08 2002-12-19 Novartis Ag Ophthalmic once-a-day composition
AR034371A1 (es) * 2001-06-08 2004-02-18 Novartis Ag Composiciones farmaceuticas
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
US6743439B1 (en) * 2001-06-27 2004-06-01 Alcon, Inc. Ophthalmic compositions containing copolymers of sulfonated styrene and maleic anhydride
US6635654B1 (en) * 2003-01-09 2003-10-21 Allergan, Inc. Ophthalmic compositions containing loratadine

Also Published As

Publication number Publication date
JP2007099769A (ja) 2007-04-19
EP1774961A3 (en) 2007-09-05
AR056558A1 (es) 2007-10-10
CN1939277A (zh) 2007-04-04
EP1774961A2 (en) 2007-04-18
CA2561694A1 (en) 2007-03-30
TW201247243A (en) 2012-12-01
KR20070037402A (ko) 2007-04-04
TWI427052B (zh) 2014-02-21
TW200728247A (en) 2007-08-01
AU2006225171B2 (en) 2012-04-26
SG131102A1 (en) 2007-04-26
TWI435735B (zh) 2014-05-01
AU2006225171A1 (en) 2007-04-19
US20070077302A1 (en) 2007-04-05

Similar Documents

Publication Publication Date Title
GT201000114A (es) "mezclas fungicidas"
BR112015001618A2 (pt) composições fungicidas
BRPI0609393B8 (pt) usos de um composto 11-desóxi-prostaglandina
BRPI0922824A8 (pt) compostos n-oxipiperidinas espiro-heterocíclicas como pesticidas, seu processo de preparação, composição pesticida que as contém e método de combater e controlar pestes
BRPI0621446C1 (pt) composição farmacêutica para uso externo
BRPI0607018A2 (pt) combinações sinérgicas de compostos ativas fungicidas
BRPI0609121B8 (pt) 1h-benzimidazol-4-carboxamidas substituídas com um carbono quaternário na posição 2
CY1119269T1 (el) Θεραπεια βλαβων που προκαλουνται απο ιους
BRPI0520870B8 (pt) compostos intermediários para a preparação de alfa-mercaptoacetanilidas de s-triazolila
UY28800A1 (es) 5,6-dialquil-7-amino-triazolopirimidinas, procedimientos para su preparación y el uso de las mismas para combatir hongos nocivos
BRPI0720991A8 (pt) Preparação da romidepsina
BR112013028474A2 (pt) extrator de tendão do quadríceps
ECSP088689A (es) NOVEDOSAS 11ß-HIDROXIANDROSTA-4-EN-3-ONAS
WO2007120374A3 (en) Anti-arenaviral compounds
BR112021023927A2 (pt) Composto, e, composição farmacêutica
BR0116332A (pt) Processo para o aumento da estabilidade
BRPI0712889A8 (pt) composto, processo para a preparação de um composto, composto intermediário, e, composição farmacêutica.
BRPI0608245A2 (pt) compostos; processo para a sua fabricação; composições farmacêuticas; método para o tratamento e/ou prevenção de doenças que estejam associadas à modulação de receptores de sst subtipo 5 e uso dos compostos
CR10548A (es) 18-metil-19nor-androst-4-en-17, 17-espiroeteres (18-metil-19-nor-20-espirox-4-en-3-onas) asi como preparaciones farmaceuticas que los contienen
BR112023019622A2 (pt) Preparação contendo composto de peptídeo cíclico e método para a produção do mesmo
BRPI0418474A (pt) solução aquosa parenteral estável
BRPI0605508A (pt) métodos para estabilização de composições oftálmicas
AR062217A1 (es) Derivados de 4- trimetilamonio-3- aminobutirato y 4- trimetilfosfonio-3-aminobutirato como inhibidores de la cpt
UY30187A1 (es) Nuevas modificaciones cristalinas y solvato
CO6531477A2 (es) Composición de diagnóstico que comprende cationes en plasma con un perfil de seguridad superior

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2325 DE 28-07-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.